Evidence map›Paper›PMID 29476924›Full record

ArticleColloids and surfaces. B, Biointerfaces2018

Branched polyrotaxane hydrogels consisting of alpha-cyclodextrin and low-molecular-weight four-arm polyethylene glycol and the utility of their thixotropic property for controlled drug release.

Juan Wang, Geoffrey S Williamson, Hu Yang

Abstract read
In one paragraph

Article in Colloids and surfaces. B, Biointerfaces, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
3.4field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 47 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Review
  5. Review
  6. Review
  7. Article
  8. Review
  9. "Double-punch" strategy for delivery of viral immunotherapy with prolonged tumor retention and enhanced transfection efficacy.Journal of controlled release : official journal of the Controlled Release Society · 2021
    Article
  10. Article
  11. Article
  12. Review
  13. α-Cyclodextrin-Based Polypseudorotaxane Hydrogels.Materials (Basel, Switzerland) · 2019
    Review
  14. Review
  15. Article
  16. Review
  17. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Juan WangDepartment of Chemical and Life Science Engineering, Virginia Commonwealth University, Richmond, VA 23219, United States.
Geoffrey S WilliamsonDepartment of Biomedical Engineering, Virginia Commonwealth University, Richmond, VA 23284, United States.
Hu YangDepartment of Chemical and Life Science Engineering, Virginia Commonwealth University, Richmond, VA 23219, United States; Department of Biomedical Engineering, Virginia Commonwealth University, Richmond, VA 23284, United States; Department of Pharmaceutics, Virginia Commonwealth University, Richmond, VA 23298, United States; Massey Cancer Center, Virginia Commonwealth University, Richmond, VA 23298, United States. Electronic address: hyang2@vcu.edu.
Virginia Commonwealth University · US

Funding

Hybrid Nanoparticles for GlaucomaR01EY024072 · NEI · VIRGINIA COMMONWEALTH UNIVERSITY · PI KOMPELLA, UDAY B, YANG, HU · 2014 to 2016
$1.3M
NEI NIH HHS R01 EY024072
6 · The paper itself

Abstract

In this work, we developed a new class of branched polyrotaxane hydrogel made of 4-arm polyethylene glycol (4-PEG) and α-cyclodextrin (α-CD) using supramolecular host-guest interactions as a cross-linking strategy. Because of the dynamic nature of the non-covalent host-guest cross-linking, the resulting supramolecular α-CD/4-PEG hydrogels show thixotropic behavior and undergo a reversible gel-sol transition in response to shear stress change. We loaded the antiglaucoma drug brimonidine into the α-CD/4-PEG gel and found the drug release kinetics was controlled by shear stress. This thixotropic shear thinning property makes the supramolecular hydrogels highly attractive in drug delivery applications and suitable for preparation of injectable drug formulations.

Indexed as

Chemical Phenomenaalpha-CyclodextrinsBrimonidine TartrateCyclodextrinsDelayed-Action PreparationsDrug LiberationHydrogelsKineticsMolecular WeightPoloxamerPolyethylene GlycolsRheologyRotaxanesalpha-cyclodextrinalpha-CyclodextrinsBrimonidine TartrateCyclodextrinsDelayed-Action PreparationsHydrogelsPoloxamerPolyethylene GlycolspolyrotaxaneRotaxanesBranched PEGGlaucomaHost-guest interactionSupramolecularThixotropic

Identifiers

PMID29476924
PMCPMC5882578
OpenAlexW2791031869

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.